SCHEDULE 13D/A: Major Shareholder Restructures Moolec Science SA Holdings, Consolidating Control
Beneficial Ownership Amendment
A recent SEC filing reveals a significant internal restructuring of beneficial ownership in Moolec Science SA, with Juan Jose Sartori Pineyro consolidating his control through a transfer of shares between his affiliated entities.
Summary
- This Amendment No. 1 to Schedule 13D updates the beneficial ownership of Moolec Science SA Ordinary Shares.
- The filing reports a transfer of 11,770,276 shares from Union Group Ventures Limited (UGVL) to Arvesa Corp, both entities ultimately controlled by Juan Jose Sartori Pineyro.
- As a result of this transfer, Arvesa Corp has been added as a new reporting person.
- The beneficial ownership percentages are calculated based on 40,126,840 outstanding shares of Moolec Science SA.
- Union Group Ventures Limited (UGVL) now beneficially owns 3,400,552 shares, representing approximately 8.5% of the outstanding capital stock.
- Union Group International Holdings Limited (UGIH), through its subsidiary UGVL, also beneficially owns 3,400,552 shares, representing approximately 8.5%.
- Arvesa Corp now beneficially owns 11,770,276 shares, representing approximately 29.3% of the outstanding capital stock.
- Juan Jose Sartori Pineyro, through UGVL, UGIH, and Arvesa, beneficially owns an aggregate of 15,170,828 shares, corresponding to approximately 37.8% of the outstanding capital stock.
- All reporting persons are companies limited by shares governed by the laws of the British Virgin Islands, except Juan Jose Sartori Pineyro, who is a Swiss citizen.
Sentiment
Score: 5
Explanation: The filing is a factual report of a change in beneficial ownership structure, not an operational or financial update, thus it carries a neutral sentiment.
Risks
- Increased concentration of ownership under Juan Jose Sartori Pineyro, which could impact corporate governance and the influence of minority shareholders.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the company's operations or financial performance.
Industry Context
This filing is a routine disclosure of changes in beneficial ownership by a significant shareholder and does not provide information directly related to broader industry trends or competitive landscape for Moolec Science SA.
Legal Proceedings
- None of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
- None of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws, or finding any violation with respect to such laws, during the last five years.
Related Party Transactions
- The filing details a transfer of 11,770,276 shares from Union Group Ventures Limited to Arvesa Corp. Both entities are wholly owned subsidiaries of Union Group International Holdings Limited, which is wholly owned by Juan Jose Sartori Pineyro, indicating an internal restructuring of holdings among related parties.
Stakeholder Impact
- Shareholders: The restructuring clarifies and consolidates the beneficial ownership and control held by Juan Jose Sartori Pineyro, potentially impacting future strategic decisions and the company's direction.
Key Dates
| Date | Description |
|---|---|
| 01/09/2023 | Original Schedule 13D filed with the SEC. |
| 01/06/2025 | Issuer's registration statement on Form F-4 filed with the SEC, reporting 40,126,840 Shares outstanding. |
| 02/06/2025 | Date of the event (share transfer) which required the filing of this statement. |
| 02/25/2025 | Date of the Joint Filing Agreement and signatures for this Amendment No. 1. |
Keywords
Moolec Science SA, Schedule 13D, beneficial ownership, share transfer, corporate control, insider ownership, Luxembourg, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.